Real-world evidence base
For Sponsors
Longitudinal follow-up, attack data, treatment response, and protocol-aligned secondary-use conversations.
The Armenian FMF cohort, presented as a sponsor-grade evidence asset.
Longitudinal follow-up, attack data, treatment response, and protocol-aligned secondary-use conversations.
The registry is embedded in an established clinical network rather than standing apart from operations.
IRB-aware, sponsor-aligned collaboration model with clear stewardship language.
Natural history, feasibility, endpoint planning, and post-marketing scenarios.
The route uses a dedicated desktop rhythm, with slide-specific heading scale, card density, and supporting route structure aligned to the presentation logic.
Use the contact flows for dossier requests, feasibility, registry collaboration, EAEU bridge questions, partner intake, or direct office follow-up.